THRN Stock Price, Thorne HealthTech, Inc. Quote, Chart

Market Summary

USD10.190.00

Delayed

0.00%

THRN Stock Price

View Fullscreen

THRN RSI Chart

THRN Valuation

Market Cap

549.4M

Price/Earnings (Trailing)

27.03

Price/Sales (Trailing)

2.14

EV/EBITDA

24.47

Price/Free Cashflow

-38.11

THRN Price/Sales (Trailing)

THRN Profitability

Operating Margin

50.35%

EBT Margin

5.64%

Return on Equity

13.21%

Return on Assets

7.2%

Free Cashflow Yield

-2.62%

THRN Fundamentals

THRN Revenue

Revenue (TTM)

257.0M

Rev. Growth (Yr)

33.08%

Rev. Growth (Qtr)

11.46%

THRN Earnings

Earnings (TTM)

20.3M

Earnings Growth (Yr)

179.52%

Earnings Growth (Qtr)

1.2K%

Breaking Down THRN Revenue

Last 30 days

0.7%

Last 90 days

106.7%

Trailing 12 Months

113.6%

How does THRN drawdown profile look like?

THRN Financial Health

Current Ratio

2.41

Debt/Equity

0.09

Debt/Cashflow

1.52

THRN Investor Care

Shares Dilution (1Y)

2.23%

Diluted EPS (TTM)

0.39

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	238.9M	257.0M	0	0
2022	193.8M	205.6M	216.0M	227.7M
2021	0	0	174.2M	184.3M
2020	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Thorne HealthTech, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jun 29, 2023	jacobson paul f	gifted	-	-	-220,377	chief executive officer
Apr 04, 2023	jacobson paul f	acquired	-	-	500,000	chief executive officer
Apr 04, 2023	jacobson paul f	sold (taxes)	-191,424	4.72	-40,556	chief executive officer
Apr 04, 2023	kauss sarah m	acquired	-	-	30,000	-
Apr 04, 2023	mccamy william c.	sold (taxes)	-35,914	4.72	-7,609	president
Apr 04, 2023	mccamy william c.	acquired	-	-	200,000	president
Apr 04, 2023	mckenna thomas p.	sold (taxes)	-110,981	4.72	-23,513	chief operating officer
Apr 04, 2023	mckenna thomas p.	acquired	-	-	400,000	chief operating officer
Apr 04, 2023	varma saloni s.	sold (taxes)	-30,349	4.72	-6,430	-
Apr 04, 2023	varma saloni s.	acquired	-	-	500,000	-

Which funds bought or sold THRN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 22, 2024	MetLife Investment Management, LLC	sold off	-100	-83,629	-	-%
Mar 11, 2024	VANGUARD GROUP INC	sold off	-100	-8,769,040	-	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	sold off	-100	-2,759,970	-	-%
Feb 28, 2024	AMERICAN INTERNATIONAL GROUP, INC.	sold off	-100	-71,412	-	-%
Feb 15, 2024	BARCLAYS PLC	sold off	-100	-521,000	-	-%
Feb 15, 2024	Legal & General Group Plc	sold off	-100	-13,502	-	-%
Feb 14, 2024	Royal Bank of Canada	sold off	-100	-295,000	-	-%
Feb 14, 2024	Sagefield Capital LP	sold off	-100	-218,168	-	-%
Feb 14, 2024	Ameritas Investment Partners, Inc.	sold off	-100	-14,337	-	-%

Are Funds Buying or Selling THRN?

Are funds buying THRN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own THRN

No. of Funds

Unveiling Thorne HealthTech, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Nov 06, 2023	kirin holdings company, ltd /fi	-	0	SC 13G/A
Oct 17, 2023	mitsui & co ltd	-	0	SC 13G/A
Feb 10, 2023	mitsui & co ltd	29.7%	15,730,750	SC 13G/A
Feb 15, 2022	jacobson paul f	14.7%	7,732,870	SC 13G
Feb 14, 2022	kirin holdings company, ltd /fi	29.9%	15,730,750	SC 13G
Feb 10, 2022	helsinn international (u.s.) corp	11.2%	5,878,005	SC 13G
Feb 09, 2022	mitsui & co ltd	29.9%	15,730,750	SC 13G

Peers (Alternatives to Thorne HealthTech, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ADM	31.5B	93.9B	-0.32%	-23.51%	9.05	0.34	-7.50%	-19.75%
BG	15.9B	61.3B	10.48%	15.10%	7.7	0.25	-8.91%	30.43%
CAG	14.9B	12.1B	7.86%	-17.10%	15.7	1.23	-0.78%	18.26%
CPB	13.4B	9.3B	3.26%	-15.93%	17.5	1.45	1.02%	-5.78%
ACI	11.7B	79.2B	-2.73%	-1.74%	9.04	0.15	2.05%	-14.37%
MID-CAP
BRBR	7.4B	1.7B	-7.89%	57.39%	44.53	4.24	21.49%	39.64%
FLO	5.2B	5.1B	7.07%	-8.76%	42.12	1.02	5.93%	-45.96%
FRPT	5.1B	766.9M	-8.53%	61.44%	-151.2	6.63	28.82%	43.50%
CALM	2.9B	2.4B	-2.42%	14.48%	10.54	1.22	-22.17%	-63.60%
CENT	2.8B	3.3B	-1.82%	42.74%	20.91	0.85	0.37%	-0.15%
SMALL-CAP
ANDE	2.0B	14.8B	7.84%	37.11%	20.2	0.14	-14.86%	-22.80%
BGS	870.4M	2.1B	-0.36%	-25.34%	-13.15	0.42	-4.65%	-482.22%
BYND	392.6M	343.4M	-23.16%	-56.61%	-1.16	1.14	-18.04%	7.65%
ALCO	215.5M	106.3M	-1.29%	17.59%	4.5	2.03	34.67%	5930.90%
AQB	7.1M	2.5M	-15.71%	210.53%	-0.26	2.85	-21.18%	-24.37%

Thorne HealthTech, Inc. News

Latest updates

Thorne HealthTech, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)											(In Thousands)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q3
Revenue	11.5%	72,715	65,238	60,609	58,419	54,641	54,030	48,918	48,010	42,890	44,484	38,774
Cost Of Revenue	3.6%	32,077	30,964	34,303	30,239	24,704	24,551	24,182	22,470	19,994	21,247	19,445
Gross Profit	18.6%	40,637	34,274	26,306	28,180	29,937	29,479	24,736	25,540	22,896	23,237	19,329
S&GA Expenses	-4.7%	22,471	23,578	20,958	18,340	18,505	17,928	19,388	13,430	12,334	11,237	13,478
R&D Expenses	-15.0%	1,506	1,772	1,874	1,815	1,744	1,968	1,620	2,237	1,136	907	552
EBITDA Margin	118.2%	0.08*	0.04*	-	-	0.04*	0.08*	0.09*	0.07*	0.10*	-	0.13*
Interest Expenses	37.7%	394	286	105	34.00	46.00	32.00	777	-29.09	70.00	302	-
Income Taxes	7141.4%	2,100	29.00	-7,517	-	175	33.00	289	79.00	3.00	41.00	48.00
Earnings Before Taxes	1613.0%	6,257	-413	5,070	3,587	-5,603	4,744	2,170	1,161	2,785	4,804	4,829
EBT Margin	410.7%	0.06*	0.01*	0.03*	0.02*	0.01*	0.06*	0.06*	-	-	-	-
Net Income	1205.5%	4,446	-402	12,547	3,739	-5,590	4,979	1,606	1,029	-88.23	4,706	3,577
Net Income Margin	83.6%	0.08*	0.04*	0.07*	0.02*	0.01*	0.04*	0.04*	-	-	-	-
Free Cashflow	137.8%	7,136	-18,898	2,145	-4,800	-3,240	-5,993	758	4,267	-8,448	8,198	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet									(In Millions)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2020Q4
Assets	17.3%	283	241	230	191	189	186	175	194	115
Current Assets	17.4%	135	115	117	99.00	101	95.00	101	125	47.00
Cash Equivalents	54.5%	17.00	11.00	36.00	23.00	33.00	36.00	56.00	77.00	15.00
Inventory	18.1%	72.00	61.00	59.00	61.00	60.00	50.00	41.00	38.00	28.00
Net PPE	11.0%	65.00	59.00	49.00	33.00	31.00	31.00	27.00	25.00	23.00
Goodwill	0%	20.00	20.00	20.00	17.00	17.00	17.00	14.00	14.00	14.00
Liabilities	38.5%	127	92.00	83.00	59.00	64.00	58.00	57.00	80.00	69.00
Current Liabilities	76.3%	56.00	32.00	40.00	29.00	35.00	27.00	26.00	47.00	16.00
Long Term Debt	3.0%	14.00	14.00	13.00	1.00	-	-	1.00	-	-
LT Debt, Current	-2.9%	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00
LT Debt, Non Current	3.0%	14.00	14.00	13.00	1.00	-	-	1.00	-	-
Shareholder's Equity	3.3%	154	149	145	130	125	128	118	114	-
Retained Earnings	3.8%	-112	-116	-116	-129	-132	-127	-132	-133	-132
Additional Paid-In Capital	0.8%	266	264	261	259	256	252	250	247	52.00
Shares Outstanding	0.7%	54.00	54.00	53.00	53.00	53.00	53.00	53.00	19.00	12.00
Minority Interest	-7.4%	1.00	2.00	2.00	2.00	2.00	2.00	-0.20	-0.11	-6.45

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)												(In Thousands)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Cashflow From Operations	362.2%	15,012	-5,725	14,023	-1,793	-2,506	-4,501	2,944	5,254	-7,900	8,787	-	-
Share Based Compensation	-23.3%	2,873	3,748	2,929	3,255	3,142	2,009	3,129	891	24.00	511	-	-
Cashflow From Investing	53.6%	-8,063	-17,360	-11,966	-3,195	-733	-17,729	-3,078	-986	-2,523	-589	-	-
Cashflow From Financing	-145.2%	-6,244	13,808	11,157	-167	-231	2,599	-20,555	62,704	-3,189	-125	-	-

THRN Income Statement

2023-06-30

Condensed Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Net sales	$ 72,714,600	$ 54,640,936	$ 137,952,379	$ 108,670,636
Cost of sales	32,077,213	24,704,294	63,041,402	49,254,885
Gross profit	40,637,387	29,936,642	74,910,977	59,415,751
Operating expenses:
Research and development	1,506,149	1,743,812	3,278,238	3,711,478
Marketing	10,037,781	15,841,490	18,976,472	20,642,450
Selling, general, and administrative	22,470,851	18,504,691	46,048,391	36,433,167
Income from operations	6,622,606	(6,153,351)	6,607,876	(1,371,344)
Other income (expense), net:
Interest expense, net	(583,145)	(31,514)	(978,144)	(61,671)
Change in fair value of warrant liability	(19,210)	594,899	(357,566)	528,980
Other income, net	236,787	(13,761)	571,318	44,094
Total other income (expense), net	(365,568)	549,624	(764,392)	511,403
(Loss) income before income taxes and loss from equity interests in unconsolidated affiliates	6,257,038	(5,603,727)	5,843,484	(859,941)
Income tax expense	2,124,000	174,553	2,153,000	207,098
Net (loss) income before loss from equity interests in unconsolidated affiliates	4,133,038	(5,778,280)	3,690,484	(1,067,039)
Net income (loss) before gain from equity interests in unconsolidated affiliatesGain from equity interests in unconsolidated affiliates	198,964	11,037	110,030	11,037
Net (loss) income	4,332,002	(5,767,243)	3,800,514	(1,056,002)
Net loss-non-controlling interests	(113,817)	(176,538)	(243,141)	(444,356)
Net (loss) income attributable to Thorne HealthTech, Inc.	4,445,819	(5,590,705)	4,043,655	(611,646)
Net (loss) income attributable to common stockholders	$ 4,445,819	$ (5,590,705)	$ 4,043,655	$ (611,646)
(Loss) earnings per share:
Basic	$ 0.08	$ (0.11)	$ 0.08	$ (0.01)
Diluted	$ 0.08	$ (0.11)	$ 0.08	$ (0.01)
Weighted average common shares outstanding:
Basic	53,866,857	52,731,604	53,606,294	52,648,653
Diluted	53,866,857	52,731,604	53,606,294	52,648,653

THRN Balance Sheet

2023-06-30

Condensed Consolidated Balance Sheets (unaudited) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 17,093,556	$ 36,024,847
Restricted cash	15,201,129	4,900,000
Accounts receivable, net	25,406,854	14,367,785
Related party receivables	159,528	68,731
Inventories, net	71,685,307	58,643,928
Prepaid expenses and other current assets	5,919,447	2,615,593
Total current assets	135,465,821	116,620,884
Long-term Assets
Property and equipment, net	65,324,802	49,176,844
Operating lease right-of-use assets, net	33,588,576	17,546,240
Finance lease right-of-use assets, net	2,734,096	3,143,592
Intangible assets, net	14,887,063	11,830,249
Goodwill	20,041,040	20,041,040
Investments	1,400,000	1,400,000
Equity-method investments	981,726	942,501
Other related party receivables	0	153,556
Deferred tax assets	6,942,187	7,782,187
Other assets	1,162,138	1,166,928
Total assets	282,527,449	229,804,021
Current Liabilities
Accounts payable	40,556,301	26,997,203
Accrued payroll	4,333,786	3,508,583
Other accrued Liabilities	5,795,887	3,563,843
Related party payable	443,670	988,778
Current portion of operating lease liabilities	2,491,641	1,504,433
Current portion of finance lease liabilities	1,742,661	1,660,404
Notes payable	116,368	814,576
Current portion of long-term debt	764,766	523,510
Total current liabilities	56,245,080	39,561,330
Long-term Liabilities
Revolving line of credit	10,000,000	0
Operating lease liabilities, net of current portion	44,372,844	28,430,474
Finance lease liabilities, net of current portion	1,125,607	1,455,011
Long-term debt, net of current portion	14,111,906	12,646,049
Warrant liability	1,416,909	1,059,343
Total liabilities	127,272,346	83,152,207
Commitments and Contingencies (Note 18)
Stockholders' Equity
Common stock; par value $0.01, 200,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 53,920,021 and 53,289,685 issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	543,714	534,875
Treasury stock	(21,950)	(9,678)
Additional paid-in capital	265,697,111	260,978,339
Accumulated deficit	(112,296,636)	(116,483,976)
Accumulated other comprehensive loss	(85,385)	(29,136)
Total stockholders equity-Thorne HealthTech, Inc.	153,836,854	144,990,424
Non-controlling interest	1,418,249	1,661,390
Total stockholders' equity	155,255,103	146,651,814
Total liabilities and stockholders equity	$ 282,527,449	$ 229,804,021

About Thorne HealthTech, Inc.

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

CEO	Mr. Paul F. Jacobson
WEBSITE	thorne.com
INDUSTRY	Packaged Foods
EMPLOYEES	544

Thorne HealthTech, Inc. Frequently Asked Questions

What is the ticker symbol for Thorne HealthTech, Inc.? What does THRN stand for in stocks?

THRN is the stock ticker symbol of Thorne HealthTech, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Thorne HealthTech, Inc. (THRN)?

As of Mon Oct 16 2023, market cap of Thorne HealthTech, Inc. is 549.45 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of THRN stock?

You can check THRN's fair value in chart for subscribers.

What is the fair value of THRN stock?

You can check THRN's fair value in chart for subscribers. The fair value of Thorne HealthTech, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Thorne HealthTech, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for THRN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Thorne HealthTech, Inc. a good stock to buy?

The fair value guage provides a quick view whether THRN is over valued or under valued. Whether Thorne HealthTech, Inc. is cheap or expensive depends on the assumptions which impact Thorne HealthTech, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for THRN.

What is Thorne HealthTech, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Oct 16 2023, THRN's PE ratio (Price to Earnings) is 27.03 and Price to Sales (PS) ratio is 2.14. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. THRN PE ratio will change depending on the future growth rate expectations of investors.